Idera Pharmaceuticals Investor
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Technology:
Others
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1989-01-01
Employees Number:
51-100
Funding Status:
IPO
Investors Number:
4
Total Funding:
74500000
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership